Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine in high risk sickle cell disease
NCT01375608Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Jun 2011
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of decitabine in sickle cell disease (SCD), sponsored by National Heart, Lung, and Blood Institute. Started Jun 2011; status: completed.
02
Drugs
decitabine
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT01375608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01375608.